Cardiometabolic Risk Profile in Acute Coronary Syndrome Patients

Priscilla, Paşc; Coţe, Ioana Alexandra; Popescu, Mircea Ioachim

doi:10.2478/inmed-2020-0126

Abstract

Cardiometabolic syndrome (CMS), also known as metabolic syndrome X or insulin resistance syndrome is a cluster of metabolic abnormalities including central obesity associated with hyperglycemia, dyslipidemia or hypertension. Each component of CMS is individually associated with an increased risk of coronary events and has a different impact on outcomes and long-term mortality.

References

1. Grundy SM (2008) Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28: 629-636.10.1161/ATVBAHA.107.15109218174459
Search in Google Scholar Back to article
2. Hossain P, Kawar B, El Nahas M (2007) Obesity and diabetes in the developing world--a growing challenge.N Engl J Med 356: 213-21510.1056/NEJMp06817717229948
Search in Google Scholar Back to article
3. Ana Jovera, Emili Corbellab, Anna Muñoz Prevalence of Metabolic Syndrome and its Components in Patients With Acute Coronary Syndrome, Revista Espaniola de Cardiologia, pages 579-586 (July 2011)10.1016/j.rec.2011.03.009
Search in Google Scholar Back to article
4. Victor Blaton, How is the Metabolic Syndrome Related to the Dyslipidemia?, EJIFCC. 2007 Feb; 18(1): 1522
Search in Google Scholar Back to article
5. Ryan Lahey, Sadiya S. Khan,Trends in Obesity and Risk of Cardiovascular Disease, Curr Epidemiol Rep. 2018 Sep; 5(3): 243251.10.1007/s40471-018-0160-1634939230705802
Search in Google Scholar Back to article
6. Thang S Han, Mike EJ Lean, A clinical perspective of obesity, metabolic syndrome and cardiovascular disease, JRSM Cardiovasc Dis. 2016 Jan-Dec; 5,10.1177/2048004016633371478007026998259
Search in Google Scholar Back to article
7. Giuseppe Mulč, Ilenia Calcaterra,, Metabolic syndrome in hypertensive patients: An unholy alliance, World J Cardiol. 2014 Sep 26; 6(9): 890907.10.4330/wjc.v6.i9.890417679925276291
Search in Google Scholar Back to article
8. Hidekatsu Yanai, Yoshiharu Tomono, The underlying mechanisms for development of hypertension in the metabolic syndrome, Nutr J. 2008; 7: 10.10.1186/1475-2891-7-10233511318416854
Search in Google Scholar Back to article
9. D Porte JrMechanisms for Hyperglycemia in the Metabolic Syndrome. The Key Role of Beta-Cell Dysfunction, Ann N Y Acad Sci 1999 Nov 18;892:73-8310.1111/j.1749-6632.1999.tb07786.x10842653
Search in Google Scholar Back to article
10. Abdullah M. Alshehri, Metabolic syndrome and cardiovascular risk, J Family Community Med. 2010 May-Aug; 17(2): 7378.10.4103/1319-1683.71987304509821359028
Search in Google Scholar Back to article
11. Mottillo S, Filion KB, Genest J, et al. The metabolic syn-drome and cardiovascular risk a systematic review andmeta-analysis.J Am Coll Cardiol2010; 56: 11131132.10.1016/j.jacc.2010.05.03420863953
Search in Google Scholar Back to article
12. Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. Transl Res. 2017;183:5770. doi:10.1016/j.trsl. 2017.01.001
Search in Google Scholar Back to article
13. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: Time for a critical appraisal: Joint statement fromthe American Diabetes Association and the EuropeanAssociation for the Study of Diabetes.Diabetes Care2005; 28: 22892304
Search in Google Scholar Back to article
14. Feinberg, M. S., Schwartz, R., & Behar, S. (2008). Impact of Metabolic Syndrome in Patients with Acute Coronary Syndrome. Advances in Cardiology, 114126.10.1159/00011519118230959
Search in Google Scholar Back to article
15. Marko Mornar Jelavic, Md;, Zdravko Babic, Md, Phd; & Hrvoje Pintaric, Md, Phd Metabolic syndrome: influence on clinical severity and prognosis in patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention Journal Acta Cardiologica Volume 70, 2015 - Issue 2 P149-15610.1080/AC.70.2.3073505
Search in Google Scholar Back to article
16. Kazlauskienë, L., Butnorienë, J. & Norkus, A. Metabolic syndrome related to cardiovascular events in a 10-year prospective study. Diabetol Metab Syndr 7, 102 (2015)10.1186/s13098-015-0096-2465390926594246
Search in Google Scholar Back to article
17. Bundhun, P. K., Wu, Z. J., & Chen, M.-H. (2015). Impact of Modifiable Cardiovascular Risk Factors on Mortality After Percutaneous Coronary Intervention. Medicine, 94(50), e231310.1097/MD.0000000000002313505894226683970
Search in Google Scholar Back to article

Cardiometabolic Risk Profile in Acute Coronary Syndrome Patients

Abstract

Paradigm

My account